[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346554-105":59,"doc-detail-346554-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-influence-of-extracellular-citrate-in-physiological-concentration-on-the-proliferation-of-malignant-melanoma","The Influence of Extracellular Citrate in Physiological Concentration on the Proliferation of Malignant Melanoma","","Cancer cells depend on citrate to support multiple metabolic processes, making extracellular citrate availability a potential therapeutic target in malignant melanoma. The plasma membrane citrate transporter (pmCiC) is implicated in cancer biology and can be inhibited by gluconate. Patient tissue analyses assessed pmCiC expression and clinical correlations, while melanoma cells were tested in physiological citrate ± gluconate to measure proliferation rates. pmCiC was frequent in melanomas and metastases and promoted citrate-driven proliferation, which gluconate effectively blocked.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-influence-of-extracellular-citrate-in-physiological-concentration-on-the-proliferation-of-malignant-melanoma/346554/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-influence-of-extracellular-citrate-in-physiological-concentration-on-the-proliferation-of-malignant-melanoma/346554.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why focus on extracellular citrate in malignant melanoma?","Question",{"text":112,"@type":113},"Cancer cells use citrate for key metabolic functions, suggesting that limiting extracellular citrate may provide a therapeutic approach. The study specifically evaluates citrate’s effects in malignant melanoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does pmCiC relate to citrate uptake in this study?",{"text":117,"@type":113},"pmCiC is a plasma membrane citrate transporter implicated in cancer progression. The study measures pmCiC expression in patient tissues and tests citrate-driven effects in melanoma cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What effect does gluconate have on citrate-induced melanoma cell proliferation?",{"text":121,"@type":113},"Gluconate inhibits pmCiC, and the study shows it blocks the increased proliferation seen when melanoma cells are exposed to extracellular citrate in physiological concentration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346554,1790291774,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Journal of Cellular and Molecular Medicine   \n ORIGINAL ARTICLE  OPEN ACCESS   \nThe Influence of Extracellular Citrate in Physiological Concentration on the Proliferation of Malignant Melanoma  \nKonstantin Drexler1  | Barbara Schwertner1 | Veronika Zenderowski1 | Laura Schreieder1  | Dennis Christoph Harrer2  | Mark Berneburg1 | Edward Geissler3 | Maria Mycielska4 | Sebastian Haferkamp1  \n1Department of Dermatology, University Hospital Regensburg, Regensburg, Germany | 2Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany | 3Department of Surgery, University Hospital Regensburg, Regensburg, Germany | 4Department of Structural Biology, Institute of Biophysics and Physical Biochemistry, University of Regensburg, Regensburg, Germany  \nCorrespondence: Konstantin Drexler ([konstantin.drexler@ukr.de](konstantin.drexler@ukr.de))  \nReceived: 18 August 2025 | Revised: 20 January 2026 | Accepted: 19 February 2026  \nKeywords: citrate | gluconate | malignant melanoma | pmCiC  \nABSTRACT  \nCancer cells rely on citrate for multiple metabolic processes, suggesting that limiting the availability of extracellular citrate may represent a novel therapeutic strategy. The plasma membrane citrate transporter (pmCiC) has been implicated in the pathogenesis of several cancers before, and its activity can be inhibited by gluconate. Tissue samples from patients were stained, and pmCiC expression was analysed and correlated with clinical course. Melanoma cells were treated with or without citrate in physiological concentration and with or without gluconate, a pmCiC inhibitor. Cell proliferation rates were subsequently measured. pmCiC expression was observed in 58.2% of primary melanomas and 76.5% of melanoma metastases, but only in 22.2% of benign nevi. However, pmCiC expression did not correlate with the response to novel melanoma-specific therapies. In the presence of pmCiC, melanoma cells exhibited significantly increased proliferation when exposed to extracellular citrate. This effect was blocked by the addition of gluconate. Extracellular citrate uptake via pmCiC appears to contribute to the pathogenesis of malignant melanoma. Notably, inhibition of pmCiC by gluconate effectively suppressed citrate-induced proliferation.  \n1 | Introduction  \nMalignant melanoma is responsible for over 90% of skin cancerrelated deaths, with tumour thickness closely correlating with aggressiveness and metastatic potential. While early-stage prognosis is favourable, treating advanced disease remains challenging. Recent therapies, such as immune checkpoint inhibitors (anti-PD-1, anti-CTLA-4) and BRAF/MEK inhibitors, have improved survival, yet novel treatment strategies are still needed [1].  \nTumour metabolism has emerged as a critical driver of cancer progression. Unlike normal cells, cancer cells reprogram their metabolism to support proliferation, survival and adaptation [2] . Citrate, a central molecule in the mitochondrial Krebs cycle and the primary substrate in fatty acid synthesis—a hallmark of cancer—plays a key role in energy production and biosynthesis  \nof different metabolites [3, 4] . Recent studies suggest that cancer cells can manipulate extracellular citrate levels, influencing the tumour microenvironment. Low intracellular citrate can triggerstromal cells—such as cancer-associated fibroblasts—to release more citrate, which is associated with metastatic behaviour [5, 6] . A plasma membrane variant of the mitochondrial citrate transporter, known as pmCiC, has been identified in several cancers, showing a percentage of positive vs. negative tumours in 55% of breast cancers, 54% of gastric cancers, 86% of pancreatic cancers, and 86% of merkel cell carcinoma, where it enables citrate uptake for anabolic processes like fatty acid synthesis [5, 7, 8] . pmCiC expression has been linked to tumour aggressiveness across different entities, like lung, prostate and urothelial cancer [9] and was recently s","cbCaipx4JGBcsJvJ","https://ap.wps.com/l/cbCaipx4JGBcsJvJ","pdf",788585,"English","# Abstract\n# Introduction\n# Methods\n## Immunohistochemistry","[{\"question\":\"Why focus on extracellular citrate in malignant melanoma?\",\"answer\":\"Cancer cells use citrate for key metabolic functions, suggesting that limiting extracellular citrate may provide a therapeutic approach. The study specifically evaluates citrate’s effects in malignant melanoma.\"},{\"question\":\"How does pmCiC relate to citrate uptake in this study?\",\"answer\":\"pmCiC is a plasma membrane citrate transporter implicated in cancer progression. The study measures pmCiC expression in patient tissues and tests citrate-driven effects in melanoma cells.\"},{\"question\":\"What effect does gluconate have on citrate-induced melanoma cell proliferation?\",\"answer\":\"Gluconate inhibits pmCiC, and the study shows it blocks the increased proliferation seen when melanoma cells are exposed to extracellular citrate in physiological concentration.\"}]","The Influence of Extracellular Citrate in Physiological Concentration on the Proliferation of Malignant Melanoma | PDF",1790061959,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d531e764b8d4482380e7fa77fdd10703.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20b8a224bf4ee01be428dd751274c729.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00370e5ae78a141005d5899778d062ba.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a141f21c93d718e315a50aeef1541097.webp",980,1287]